Standardized, risk-adapted induction therapy in kidney transplantation

被引：0
|
作者：
Felix Eisinger
Thomas Mühlbacher
Ario Na
Karina Althaus
Silvio Nadalin
Andreas L. Birkenfeld
Nils Heyne
Martina Guthoff
机构：
[1] University of Tübingen,Department of Diabetology, Endocrinology, Nephrology
[2] University of Tübingen,Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich
[3] German Center for Diabetes Research (DZD e.V.),Department of General
[4] University of Tübingen,, Visceral
[5] University of Tübingen, and Transplant Surgery
来源：
Journal of Nephrology | 2023年 / 36卷 / 7期
关键词：
Kidney transplantation; Induction therapy; Immunological risk; Standard operating procedure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2133 / 2138
页数：5
相关论文
共 50 条
  • [41] On the Need for Phase III Studies of Risk-Adapted Therapy in Multiple Myeloma
    Voorhees, Peter
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 181 - 182
  • [42] Application of risk-adapted therapy for acute myeloid leukemia to a population. Effects of stem cell transplantation on outcome
    Wahlin, A
    Brune, ML
    Billstrom, R
    [J]. BLOOD, 2004, 104 (11) : 195B - 195B
  • [43] Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach
    Lodewyck, Tom
    Cornelissen, Jan J.
    [J]. BLOOD REVIEWS, 2008, 22 (06) : 293 - 302
  • [44] Risk-adapted adjuvant therapy of luminal early breast cancer in 2020
    Harbeck, Nadia
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2021, 33 (01) : 53 - 58
  • [45] Outcome of risk-adapted therapy for pediatric acute lymphoblastic leukemia in Egypt
    Sidhom, Iman A.
    Mokhles, Abir
    Soliman, Sonya
    Shaaban, Khaled
    Salem, Sherine
    Yassin, Dina
    Hassanein, Hala
    Hamdy, Nayera
    Rashed, Waffa
    El-Nashar, Amr
    Magdi, Hadeel
    Elhaddad, Alaa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] Risk-adapted strategy for the kidney-sparing management of upper tract tumours
    Seisen, Thomas
    Colin, Pierre
    Roupret, Morgan
    [J]. NATURE REVIEWS UROLOGY, 2015, 12 (03) : 155 - 166
  • [47] Risk-adapted chemotherapy in childhood medulloblastoma
    Varan, Ali
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (05) : 771 - 780
  • [48] Upfront or Deferred Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Triplet and Quadruplet Induction and Minimal Residual Disease/Risk-Adapted Therapy
    Mo, Clifton C.
    Hartley-Brown, Monique A.
    Midha, Shonali
    Richardson, Paul G.
    [J]. CANCERS, 2023, 15 (24)
  • [49] Risk-adapted prevention of the breast cancer
    Schmutzler, Rita
    [J]. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2009, 59 (11): : 595 - 596
  • [50] Risk-adapted use of intravesical immunotherapy
    Braasch, Matthew R.
    Boehle, Andreas
    O'Donnell, Michael A.
    [J]. BJU INTERNATIONAL, 2008, 102 (09) : 1254 - 1264
12345